Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Observational × acalabrutinib × Clear all

Status

Active not recruiting 2 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 36 Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Leukemia, B-Cell 1

Interventions

Blood Specimen Collection 126 Surveys and Questionnaires 78 Observation 47 Radiotherapy 41 Drug Therapy 35 Surgical Procedures, Operative 34 Biopsy 32 Specimen Handling 28 Data Collection 28 Magnetic Resonance Imaging 20 Interviews as Topic 20 Watchful Waiting 18 Immune Checkpoint Inhibitors 17 Liquid Biopsy 16 Tomography, X-Ray Computed 15 Magnetic Resonance Spectroscopy 15 Immunotherapy 15 pembrolizumab 12 Standard of Care 12 Radiosurgery 12 Neoadjuvant Therapy 12 Ultrasonography 11 lenvatinib 10 Nivolumab 10 Carboplatin 10 trastuzumab deruxtecan 9 Tissue Banks 9 Radiation 9 Endoscopy 9 Endoscopic Mucosal Resection 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05557695 2026-03-10

EPIC

AstraZeneca

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡